Last reviewed · How we verify
Placebo booster — Competitive Intelligence Brief
phase 3
Biologic
Live · refreshed every 30 min
Target snapshot
Placebo booster (Placebo booster) — Arcturus Therapeutics, Inc.. A placebo booster is a formulation designed to enhance the placebo effect through optimized delivery or presentation characteristics.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo booster TARGET | Placebo booster | Arcturus Therapeutics, Inc. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo booster CI watch — RSS
- Placebo booster CI watch — Atom
- Placebo booster CI watch — JSON
- Placebo booster alone — RSS
Cite this brief
Drug Landscape (2026). Placebo booster — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-booster. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing